GSK expects sales and profit at top end of forecast range after second-quarter beat
The company is focusing on expanding its drug pipeline, particularly in infectious diseases, to offset declining sales of top drugs and vaccines as demand slows and competition increases, and meet its long-term sales target.
GSK said it was well positioned to weather any financial impact from tariffs, and its outlook had factored in levies implemented so far and expected tariffs on European goods.
The European Union-U.S. trade deal announced over the weekend will result in a 15% tariff on most goods, including pharmaceuticals, shipped from the region.
GSK has forecast 2025 revenue to increase between 3% and 5%, with core profit growth per share of 6% to 8%.
"GSK's strong momentum in 2025 continues with another quarter of excellent performance driven mainly by specialty medicines, our largest business, with double-digit sales growth in respiratory, immunology & inflammation, oncology and HIV," CEO Emma Walmsley said in a statement.
Overall, turnover rose 6% to nearly 8 billion pounds ($10.68 billion) on constant currency rates, GSK said, while adjusted earnings stood at 46.5 pence per share for the second quarter.
Analysts expected earnings of 42.8 pence per share on revenue of 7.80 billion pounds, according to a company-compiled consensus.
($1 = 0.7491 pounds)
Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Daily Mail
4 hours ago
- Daily Mail
DAILY MAIL COMMENT: Keir Starmer must fight for UK drug firms
The life sciences industry is among the brightest jewels in the British economy, generating £100billion a year and employing more than 300,000 people. At its heart is the development and manufacture of pharmaceuticals, notably by AstraZeneca, which spends vast sums on research and is worth £167billion. So, if this hugely successful company were to relocate to the US, it would be a disaster both for the London Stock Exchange and the wider economy. Worryingly, this is not out of the question. AstraZeneca already sells 40 per cent of its drugs to America and, following President Donald Trump 's tariff threat, is ramping up research and production there. While there are no immediate plans to desert the UK, chief executive Pascal Soriot is said to be 'flirting' with the idea. Mr Trump's latest demand that foreign drug companies cut prices to US customers or face penalties may be an added incentive. The Left has always been highly critical of 'Big Pharma', accusing it of profiteering on the backs of NHS patients. Under Jeremy Corbyn, Labour planned to create a state-owned drug manufacturer with the power to override the patents which enable firms to make profits from their research. Only last year, Sir Keir Starmer refused to help fund a new vaccine plant in Liverpool – while pouring public money into our ailing steel industry. This Government must understand that failing to nurture AstraZeneca, GSK and others would be a catastrophic mistake. And Sir Keir should realise that while they say they want to remain in the UK, they may yet change their mind. Car lenders off hook Banks and credit providers will have heaved a huge sigh of relief yesterday after the Supreme Court ruled they will not have to pay compensation to millions of motorists who bought cars on finance without being told the dealers were receiving commission on the loan. The Treasury was also delighted with the result. Had it gone the other way, damages could have been comparable to the PPI scandal, which destabilised the financial industry for more than a decade. The court decided that dealers did not have a duty to act solely for buyers and that commissions were not a form of bribery in the legal sense, as had been alleged. However, it was not a total exoneration. Court President Lord Reed also ruled that excessive commission payments were unfair and ordered one buyer who had been charged 25 per cent of the value of the car to be repaid with interest. This opens the way to further claims. Many brokers and dealers were paid behind-the-scenes commission by lenders to sign buyers up to car finance deals, a practice deemed 'unlawful' by the Court of Appeal in October last year - a decision that was successfully appealed by lenders at the Supreme Court The dealers and lenders have escaped their worst fears, but they do not come out well. They have certainly been guilty of sharp practices even if not illegal ones. The Competition and Markets Authority must now force them to clean up their act. OAPs feel the cold In September, Rachel Reeves promised she would 'put more money in pensioners' pockets'. What she didn't say is that she would take even more out. Research shows pensioner households are an average of £800 worse off after a year of Labour thanks to higher bills – mainly owing to the Chancellor's £40billion Budget tax raid. With more taxes coming down the track to fill Labour's ever-widening financial black hole, the cost of living is set to soar further. For all Ms Reeves' promises, the elderly are in for a bitter winter.
Reuters
6 hours ago
- Reuters
IMF lowers bar for Argentina reserves accumulation, next review due after local October elections
NEW YORK, Aug 1 (Reuters) - The International Monetary Fund lowered the bar for Argentina's reserve accumulation targets through 2026 in its $20 billion program and removed a review that was due before the country's October legislative elections as detailed in a report published Friday. Net international reserves accumulation targets were lowered through 2026, leading to a steeper accumulation curve as the 2027 target was kept in place. "The NIR accumulation target for end-December 2025 has been lowered to mainly reflect the initial shortfalls, which are gradually being addressed through the agreed corrective actions," the report said. The announcement came a day after the IMF board completed the first review of the $20 billion program approved in April. Disbursements of around $14 billion have been made for Argentina so far as part of this new program. "While early efforts to re-access international capital markets are commendable, Argentina's capacity to repay its Fund obligations remains subject to exceptional risks and continues to hinge on strong policy implementation to improve reserve coverage and sustain market access (at more favorable terms) by the time repayments to the Fund come due," said the report from IMF staff.
Scottish Sun
8 hours ago
- Scottish Sun
Nigel Farage urges Chancellor not to hike gambling taxes for horse racing
Farage's comments come after a horse racing insider voiced fears Labour could 'destroy' the industry NIGE TURF WAR Nigel Farage urges Chancellor not to hike gambling taxes for horse racing Click to share on X/Twitter (Opens in new window) Click to share on Facebook (Opens in new window) NIGEL Farage enjoys Glorious Goodwood yesterday — as he called on Chancellor Rachel Reeves to not hike gambling taxes. The Reform UK leader warned of enormous damage if the 15 per cent duty is aligned to the 21 per cent for online casino-style games. Sign up for Scottish Sun newsletter Sign up 2 Reform leader Nigel Farage has warned that horse racing should be separated from the proposed Labour bill Credit: David Hartley He said: 'I do think horse racing is different. "You're making an individual decision each time to have a bet. "There are checks and safeguards in place already.' The racing industry says finances will be badly hurt if the current rate is increased for online games. A Treasury consultation on the issue has now closed. He was speaking out as he attended the West Sussex racecourse as a guest of Scottish Dubai-based businessman Dr James Hay, who has previously donated to the Tory party. His wife Fitriani has also given £50,000 to Reform UK last year. Horse trainer John Gosden has warned British horse racing will be harmed by the punishing new betting tax. "I don't want to see our industry destroyed. It would be tragic. We are world leaders." Nigel Farage on leading the polls, being 'ready' to be PM & why he 'hopes people hate him'
